TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS

α2-adrenoceptor-activation lowers central sympathetic output, peripheral, vesicular norepinephrine release, epinephrine secretion and modulates vascular tension. We previously demonstrated that α2-adrenoceptor-mediated inhibition of basal norepinephrine release was not reflected in plasma unless re-...

Full description

Bibliographic Details
Main Authors: Torill eBerg, Jørgen eJensen
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00019/full
_version_ 1828279223198941184
author Torill eBerg
Jørgen eJensen
author_facet Torill eBerg
Jørgen eJensen
author_sort Torill eBerg
collection DOAJ
description α2-adrenoceptor-activation lowers central sympathetic output, peripheral, vesicular norepinephrine release, epinephrine secretion and modulates vascular tension. We previously demonstrated that α2-adrenoceptor-mediated inhibition of basal norepinephrine release was not reflected in plasma unless re-uptake through the norepinephrine transporter (NET) was blocked. Tyramine activates reverse norepinephrine transport through NET. Here we tested the hypothesis that tyramine, by engaging NET in release, also blocks re-uptake and therefore allows manipulation of pre-junctional α2-adrenoceptors to directly regulate norepinephrine overflow to plasma. We compared in anaesthetised spontaneously hypertensive rats (SHRs) and normotensive controls (WKYs), the effect of α2-adrenoreceptor antagonist (L-659,066) and/or agonist (clonidine) on norepinephrine overflow and increase in total peripheral vascular resistance (TPR) evoked by tyramine infusion (1.26 μmol/min/kg, 15 min) and epinephrine secretion activated by the surgical stress. TPR was computed as cardiac output, recorded as ascending aortic flow, divided by blood pressure. Plasma catecholamine concentrations after tyramine were higher in SHRs than WKYs. Pre-treatment with L-659,066 increased the catecholamine concentrations in WKYs, but only if combined with clonidine in SHRs. Clonidine alone reduced tyramine-induced norepinephrine overflow in SHRs, and epinephrine in both strains. Tyramine-induced increase in TPR was not different after clonidine, eliminated after L-659,066 and L-659,066+clonidine in WKYs, but only after L-659,066+clonidine in SHRs. We conclude that tyramine infusion does allow presynaptic regulation of vesicular release to be accurately assessed by measuring differences in plasma norepinephrine concentration. Our results indicate that pre-synaptic α2-adrenoceptor regulation of norepinephrine release from nerve vesicles and epinephrine secretion is dysfunctional in SHRs, but can be restored by clonidine.
first_indexed 2024-04-13T07:40:40Z
format Article
id doaj.art-cccd2f39b44244ee9216f5822949eb55
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T07:40:40Z
publishDate 2013-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-cccd2f39b44244ee9216f5822949eb552022-12-22T02:55:56ZengFrontiers Media S.A.Frontiers in Neurology1664-22952013-02-01410.3389/fneur.2013.0001939194TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATSTorill eBerg0Jørgen eJensen1University of OsloNorwegian School of Sport Sciencesα2-adrenoceptor-activation lowers central sympathetic output, peripheral, vesicular norepinephrine release, epinephrine secretion and modulates vascular tension. We previously demonstrated that α2-adrenoceptor-mediated inhibition of basal norepinephrine release was not reflected in plasma unless re-uptake through the norepinephrine transporter (NET) was blocked. Tyramine activates reverse norepinephrine transport through NET. Here we tested the hypothesis that tyramine, by engaging NET in release, also blocks re-uptake and therefore allows manipulation of pre-junctional α2-adrenoceptors to directly regulate norepinephrine overflow to plasma. We compared in anaesthetised spontaneously hypertensive rats (SHRs) and normotensive controls (WKYs), the effect of α2-adrenoreceptor antagonist (L-659,066) and/or agonist (clonidine) on norepinephrine overflow and increase in total peripheral vascular resistance (TPR) evoked by tyramine infusion (1.26 μmol/min/kg, 15 min) and epinephrine secretion activated by the surgical stress. TPR was computed as cardiac output, recorded as ascending aortic flow, divided by blood pressure. Plasma catecholamine concentrations after tyramine were higher in SHRs than WKYs. Pre-treatment with L-659,066 increased the catecholamine concentrations in WKYs, but only if combined with clonidine in SHRs. Clonidine alone reduced tyramine-induced norepinephrine overflow in SHRs, and epinephrine in both strains. Tyramine-induced increase in TPR was not different after clonidine, eliminated after L-659,066 and L-659,066+clonidine in WKYs, but only after L-659,066+clonidine in SHRs. We conclude that tyramine infusion does allow presynaptic regulation of vesicular release to be accurately assessed by measuring differences in plasma norepinephrine concentration. Our results indicate that pre-synaptic α2-adrenoceptor regulation of norepinephrine release from nerve vesicles and epinephrine secretion is dysfunctional in SHRs, but can be restored by clonidine.http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00019/fullEpinephrineHypertensionNorepinephrineSympathetic Nervous SystemTotal peripheral vascular resistanceα2 adrenoceptors
spellingShingle Torill eBerg
Jørgen eJensen
TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
Frontiers in Neurology
Epinephrine
Hypertension
Norepinephrine
Sympathetic Nervous System
Total peripheral vascular resistance
α2 adrenoceptors
title TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
title_full TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
title_fullStr TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
title_full_unstemmed TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
title_short TYRAMINE REVEALS FAILING α2-ADRENOCEPTOR CONTROL OF CATECHOLAMINE RELEASE AND TOTAL PERIPEHRAL VASCULAR RESISTANCE IN HYPERTENSIVE RATS
title_sort tyramine reveals failing α2 adrenoceptor control of catecholamine release and total peripehral vascular resistance in hypertensive rats
topic Epinephrine
Hypertension
Norepinephrine
Sympathetic Nervous System
Total peripheral vascular resistance
α2 adrenoceptors
url http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00019/full
work_keys_str_mv AT torilleberg tyraminerevealsfailinga2adrenoceptorcontrolofcatecholaminereleaseandtotalperipehralvascularresistanceinhypertensiverats
AT jørgenejensen tyraminerevealsfailinga2adrenoceptorcontrolofcatecholaminereleaseandtotalperipehralvascularresistanceinhypertensiverats